These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10923863)

  • 21. A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli.
    Richardson TH; Jung F; Griffin KJ; Wester M; Raucy JL; Kemper B; Bornheim LM; Hassett C; Omiecinski CJ; Johnson EF
    Arch Biochem Biophys; 1995 Oct; 323(1):87-96. PubMed ID: 7487078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies and multifunctional cytochrome P450: drug metabolism as paradigm.
    Gelboin HV; Krausz K
    J Clin Pharmacol; 2006 Mar; 46(3):353-72. PubMed ID: 16490812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A monoclonal antibody to rat liver cytochrome P450 IIC11 strongly and regiospecifically inhibits constitutive benzo[a]pyrene metabolism and DNA binding.
    Todorovic R; Devanesan PD; Cavalieri EL; Rogan EG; Park SS; Gelboin HV
    Mol Carcinog; 1991; 4(4):308-14. PubMed ID: 1872951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies inhibitory to rat hepatic cytochromes P-450: P-450 form specificities and use as probes for cytochrome P-450-dependent steroid hydroxylations.
    Waxman DJ; Lapenson DP; Park SS; Attisano C; Gelboin HV
    Mol Pharmacol; 1987 Nov; 32(5):615-24. PubMed ID: 3119986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily.
    Veronese ME; Doecke CJ; Mackenzie PI; McManus ME; Miners JO; Rees DL; Gasser R; Meyer UA; Birkett DJ
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):533-8. PubMed ID: 8424795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily.
    Ha-Duong NT; Dijols S; Marques-Soares C; Minoletti C; Dansette PM; Mansuy D
    J Med Chem; 2001 Oct; 44(22):3622-31. PubMed ID: 11606127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
    Yamazaki H; Shimada T
    Xenobiotica; 1999 Mar; 29(3):231-41. PubMed ID: 10219964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4.
    Gelboin HV; Krausz KW; Goldfarb I; Buters JT; Yang SK; Gonzalez FJ; Korzekwa KR; Shou M
    Biochem Pharmacol; 1995 Nov; 50(11):1841-50. PubMed ID: 8615863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid.
    Taguchi K; Konishi T; Nishikawa H; Kitamura S
    Xenobiotica; 1999 Sep; 29(9):899-907. PubMed ID: 10548450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
    Wester MR; Lasker JM; Johnson EF; Raucy JL
    Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9.
    Mancy A; Dijols S; Poli S; Guengerich P; Mansuy D
    Biochemistry; 1996 Dec; 35(50):16205-12. PubMed ID: 8973193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of residues 286 and 289 as critical for conferring substrate specificity of human CYP2C9 for diclofenac and ibuprofen.
    Klose TS; Ibeanu GC; Ghanayem BI; Pedersen LG; Li L; Hall SD; Goldstein JA
    Arch Biochem Biophys; 1998 Sep; 357(2):240-8. PubMed ID: 9735164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates.
    Takanashi K; Tainaka H; Kobayashi K; Yasumori T; Hosakawa M; Chiba K
    Pharmacogenetics; 2000 Mar; 10(2):95-104. PubMed ID: 10761997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib.
    Uttamsingh V; Lu C; Miwa G; Gan LS
    Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies of differentiating specificities as probes of cytochrome P450h (2C11).
    Ryan DE; Thomas PE; Levin W; Maines SL; Bandiera S; Reik LM
    Arch Biochem Biophys; 1993 Mar; 301(2):282-93. PubMed ID: 7681658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
    Teiber JF; Hollenberg PF
    Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases.
    Jung F; Richardson TH; Raucy JL; Johnson EF
    Drug Metab Dispos; 1997 Feb; 25(2):133-9. PubMed ID: 9029042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential N-demethylation of l-alpha-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4.
    Neff JA; Moody DE
    Biochem Biophys Res Commun; 2001 Jun; 284(3):751-6. PubMed ID: 11396966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
    Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
    Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies to rat liver cytochrome P-450 2c/RLM5 that regiospecifically inhibit steroid metabolism.
    Park SS; Waxman DJ; Lapenson DP; Schenkman JB; Gelboin HV
    Biochem Pharmacol; 1989 Sep; 38(18):3067-74. PubMed ID: 2783161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.